Abstract: Embodiments of the present disclosure relate to a method, apparatus, and computer readable medium for providing a security service for a data center. According to the method, a packet terminating at or originating from the data center is received. At least one label is determined for the packet, each label indicating a security requirement for the packet. Based on the at least one label, a security service chain is selected for the packet, the security service chain including an ordered set of security functions deployed in the data center and to be applied to the packet. The packet is transmitted to the selected security service chain in association with the at least one label, the packet being processed by the ordered set of security functions in the security service chain.

Abstract: The invention relates to new compounds with low cytotoxicity for blocking ubiquitination-proteasome system in diseases. Accordingly, these compounds can be used in treatment of treating disorders including, but not limited to, cancers, neurodegenerative diseases, inflammatory disorders and autoimmune disorders and metabolic disorders.

Abstract: The invention provides a soluble honokiol derivative (such as a water soluble honokiol derivative) and its application in antagonizing glycoprotein VI receptor and providing antioxidant and neuroprotective effects.

Abstract: An apparatus for security management based on event correlation in a distributed multi-layered cloud environment is disclosed, wherein the distributed multi-layered cloud environment comprises at least one first layer cloud service provider, and at least one second layer cloud service provider as a tenant of the first layer cloud service provider, and the apparatus is installed at least on one cloud service provider of the first layer cloud service provider and the second layer cloud service provider, the apparatus comprising: a central processing module configured to: provide correlation as a Service (CORRaaS) to a plurality of tenants as virtualized security appliances or virtualized security functions for the plurality of tenants's lices, generate a second interface for allowing the plurality of tenants to configure the correlation as a Service (CORRaaS), and correlate and process security events from security functions in the plurality of tenants'slices to form processed security event data, and to detect

Abstract: A device, method, apparatus and computer readable storage medium are provided for access control barring (ACB) based on cell quality. In one example, a network device determines a set of metrics related to quality of service (QoS) performance for a plurality of services in a cell in a measurement period. The network device determines ACB configuration in the cell based on comparison of the set of metrics with a set of thresholds.

Abstract: The invention relates to new compounds with low cytotoxicity for blocking ubiquitination-proteasome system in diseases. Accordingly, these compounds can be used in treatment of treating disorders including, but not limited to, cancers, neurodegenerative diseases, inflammatory disorders and autoimmune disorders and metabolic disorders.

Abstract: The invention relates to compounds for inhibiting a cancer cell or a virus. Particularly, the invention provides compounds for inhibiting, treating and/or preventing cancer and Zika virus.

Abstract: The invention relates to new compounds with low cytotoxicity for blocking the ubiquitination-proteasome system in diseases. Accordingly, these compounds can be used in treatment of disorders including, but not limited to, cancers, neurodegenerative diseases, inflammatory disorders, autoimmune disorders and metabolic disorders.

Abstract: Cloud service security management in cloud computer environment uses a first computer cloud entity with first security capabilities and under security management coordinated by a first security management service point in compliance with predefined first security requirements. Security management of a second computer cloud entity is coordinated by a second security management service point in compliance with predefined second security requirements. In the managing of the security of the cloud service in the cloud computer environment: a trusted relationship is established between the first and second security management service points, general security requirements for the cloud service are obtained; and a first security policy is defined for the first security management service point, based on the general security requirements for the cloud service, the first security capabilities and the first security requirements, for the running of the cloud service by the first computer cloud entity.

Abstract: The invention provides a series of chlorobenzene substituted azaaryl compounds having activity in inhibiting cancer cell growth and low toxicity to normal cells. Particularly, the compounds of the invention have stronger inhibition effect on bladder cancer and liver cancer.

Abstract: The invention relates to a compound of formula (I) with low cytotoxicity for blocking the ubiquitination-proteasome system in diseases. Accordingly, these compounds can be used in treatment of disorders including, but not limited to, multiple myeloma, cancers, neurodegenerative diseases, inflammatory disorders, autoimmune disorders and metabolic disorders.

Abstract: A series fan structure includes at least one first combining part and a series fan assembly, which has a first fan and a second fan mated with the first fan. The first fan has a first base and a lateral side, which together internally define a first passage. The first base is outwardly extended to form a plurality of a first supporting portions connected to the first lateral side. A first connecting space is defined among the first supporting portions and communicated with the first passage. The second fan has a second base and a lateral side, which together internally define a second passage, which is communicated with the first passage and the first connecting space. The first combining part is located in the first connecting space and connected to the first supporting portions and has a plurality of first holes communicated with the first and the second passage.

Abstract: This disclosure is related to aromatic compounds of formula (I), and methods of their use in treating medical conditions associated with Heat Shock Protein-90 (HSP90), e.g., cancer. Compounds of formula (I) have the following structure: Also disclosed are pharmaceutical compositions comprising compounds of formula (I).

Abstract: The invention discloses a method and a device for identifying pathological pictures, wherein the method comprises: obtaining sample data including a positive sample that is a pathological picture of malignant lesion and a negative sample that is a picture of normal tissue or a pathological picture of benign lesion, with a lesion area marked on the pathological picture of a malignant lesion; dividing the sample data into a training set and a testing set; training a deep neural network model using the training set; testing a trained deep neural network model using the testing set; adjusting parameters of the trained deep neural network model according to a testing result; identifying the pathological picture using the trained deep neural network model. The invention can improve the efficiency and accuracy of pathological picture identification.

Abstract: Disclosed is hydroxamic acid compounds of Formula (I) set forth herein. Also disclosed are a pharmaceutical composition containing such a compound and a method of using the compound for treating a condition associated with histone deacetylase 6.

Abstract: The invention relates to new compounds with low cytotoxicity for blocking ubiquitination-proteasome system in diseases. Accordingly, these compounds can be used in treatment of treating disorders including, but not limited to, cancers, neurodegenerative diseases, inflammatory disorders and autoimmune disorders and metabolic disorders.

Abstract: The invention provides a soluble honokiol detivative (such as a water soluble honokiol derivative) and its application in antagonizing glycoprotein VI receptor and providing antioxidant and neuroprotective effects.

Abstract: A series fan structure includes a series fan assembly and an assembling member. The series fan assembly has a first fan and a second fan. The first and second fans are correspondingly serially connected with each other. The first fan has a first fan frame defining a first receiving space. The second fan has a second fan frame defining a second receiving space. The assembling member is disposed between the first and second fan frames. The assembling member is formed with multiple straight-through perforations in communication with the first and second receiving spaces. The series fan structure improves the vibration and noise problem of the conventional series fan structure and is able to increase airflow volume.

Abstract: Fused bicycle indol, indoline, azoindole, or azoindoline compounds of Formula (I) set forth herein. Also disclosed are pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing the same. Further disclosed is a method for treating cancer, e.g., glioma, prostate cancer, and colorectal cancer, with these compounds.

Abstract: The invention provides a series of chlorobenzene substituted azaaryl compounds having activity in inhibiting cancer cell growth and low toxicity to normal cells. Particularly, the compounds of the invention have stronger inhibition effect on bladder cancer and liver cancer.